We are live on ! Find out more
PLPC icon

Preformed Line Products

67 hedge funds and large institutions have $168M invested in Preformed Line Products in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 29 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

8% more capital invested

Capital invested by funds: $156M → $168M (+$11.9M)

3% more funds holding

Funds holding: 6567 (+2)

0.06% more ownership

Funds ownership: 46.12%46.18% (+0.06%)

41% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 29

Holders
67
Holders Change
+2
Holders Change %
+3.08%
% of All Funds
1.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
17
Reduced
29
Closed
4
Calls
Puts
Net Calls
Net Calls Change

PLPC Hedge Fund Activity: Q2 2021 in Review

67 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Preformed Line Products (PLPC) for Q2 2021, worth a combined $168M — up 7.6% from $156M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new PLPC positions and 4 closed out — a net gain of 2 holders — while 17 added to existing stakes and 29 trimmed.

The largest buyer was Dean Investment Associates, opening a new position worth an estimated $1.05M. The largest seller was Royce & Associates, cutting an estimated $1.32M.

  • 67 institutional investors held Preformed Line Products (PLPC) as of Q2 2021, up from 65 in Q1 2021.
  • Funds reported $168M of Preformed Line Products stock for Q2 2021, up 7.6% quarter-over-quarter.
  • 6 funds opened new Preformed Line Products positions in Q2 2021 and 4 closed out, a net change of +2 holders.
  • The largest Preformed Line Products buyer in Q2 2021 was Dean Investment Associates, an estimated $1.05M added.
  • The largest Preformed Line Products seller in Q2 2021 was Royce & Associates, an estimated $1.32M sold.

Based on aggregated 13F filings for Q2 2021.